This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent. Top assignee: Cosmas Therapeutics Development Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Robert Zamboni and Melatonin Receptor Research.
Introduction
Robert Zamboni is an inventor associated with Beaconsfield, Canada, and Cosmas Therapeutics Development Inc. His patent work concerns compounds that act on melatonin receptors and their potential pharmaceutical applications.
Latest Patents
Zamboni is named on 1 patent: “Modulators of the melatonin receptors as well as method of manufacture and uses thereof.” The invention describes compounds of formula (I), or pharmaceutically acceptable salts, that act as melatonin MT2 agonists, along with pharmaceutical compositions containing them. It also describes potential uses for managing or treating conditions associated with melatonin receptor activity, including pain, neuropsychiatric disorders, sleep and circadian rhythm disorders, hyperthermia, and metabolic disorders.
Career Highlights
Zamboni’s listed patent reflects work on the development and potential therapeutic use of melatonin receptor modulators. He is associated with Cosmas Therapeutics Development Inc.
Collaborations
The patent information also names Gabriella Gobbi and Shiguang Li as Zamboni’s coworkers. Their shared association with the patent points to collaboration in research and development related to melatonin receptor compounds.
Conclusion
Robert Zamboni’s patent work focuses on MT2 agonists and their possible applications across several health conditions, highlighting a contribution to pharmaceutical innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile